Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 21,151–21,175 of 27,380 studies, newest first · page 847 of 1096.

December 2009 8

  1. 2009-12-01

    Increased matrix metalloproteinase 9 activity in mild cognitive impairment

    ✓ Peer-reviewed Mild cognitive impairment Journal of neuropathology and experimental neurology

    Key finding: The analysis demonstrated greater MMP-9 activity in both AD and mild cognitive impairment compared with no cognitive impairment brain samples (p < 0.01), which supports the notion that a metabolic failure in the NGF-maturation/degradation pathway may be associated with an exacerbated degradation of mNGF in the cerebral cortex in early AD. +1 more finding

  2. 2009-12-01

    Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease

    ✓ Peer-reviewed Lewy body dementia The Journal of cell biology

    Key finding: Under basal conditions, loss of VCP activity results in autophagosome accumulation. +1 more finding

  3. 2009-12-01

    Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Archives of neurology

    Key finding: Transactive response DNA-binding protein 43 pathology occurs in FAD and DS, similar to that observed in sporadic Alzheimer disease. +1 more finding

  4. 2009-12-01

    Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report

    ✓ Peer-reviewed Brain scans and imaging Archives of neurology

    Key finding: Clinical, cognitive, and CSF markers consistent with AD may precede detection of cerebral amyloid beta using amyloid imaging agents such as PiB that primarily label fibrillar amyloid beta plaques. +1 more finding

  5. 2009-12-01

    Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging

    ✓ Peer-reviewed Brain scans and imaging JAMA

    Key finding: Circulating leptin was associated with a reduced incidence of dementia and AD and with cerebral brain volume in asymptomatic older adults. +3 more findings

  6. 2009-12-01

    Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

    ✓ Peer-reviewed Brain scans and imaging Archives of neurology

    Key finding: Preclinical AD as detected by PET PiB is not benign, as it is associated with progression to symptomatic AD. +3 more findings

  7. 2009-12-01
  8. 2009-12-01

    Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial

    ✓ Peer-reviewed Genetics JAMA

    Key finding: Compared with placebo, the use of G. biloba, 120 mg twice daily, did not result in less cognitive decline in older adults with normal cognition or with mild cognitive impairment. +2 more findings

November 2009 17

  1. 2009-11-25

    Adenosine A2AReceptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway

    ✓ Peer-reviewed Disease mechanisms Journal of Neuroscience

    Key finding: Together, these results show that A(2A)Rs play a crucial role in the development of Abeta-induced synaptotoxicity leading to memory dysfunction through a p38 MAPK (mitogen-activated protein kinase)-dependent pathway and provide a molecular basis for the benefits of caffeine consumption in AD.

  2. 2009-11-25

    Prediction of pathology in primary progressive language and speech disorders

    ✓ Peer-reviewed Digital health tools Neurology

    Key finding: The different anatomic distribution of the pathologic lesions could explain these results: opercular and subcortical regions in tau pathologies with progressive anarthria, the left frontotemporal cortex in TDP-43-positive frontotemporal lobar degeneration (FTLD-TDP) with agrammatic progressive aphasia, the bilateral lateral and anterior temporal cortex in FTLD-TDP or argyrophilic grain disease with semantic dementia, and the left parietotemporal cortex in Alzheimer disease with logopenic progressive aphasia or jargon aphasia. +1 more finding

  3. 2009-11-25
  4. 2009-11-23

    Alzheimer's disease: synaptic dysfunction and Abeta

    ✓ Peer-reviewed Disease mechanisms Molecular neurodegeneration

    Key finding: Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a strong correlation between the extent of synapse loss and the severity of dementia. +3 more findings

  5. 2009-11-23

    Prediction of institutionalization in the elderly. A systematic review

    ✓ Peer-reviewed Risk factors Age and ageing

    Key finding: This study provides a systematic review of predictors of NHP in the general population of developed countries. +2 more findings

  6. 2009-11-22

    How predictive is the MMSE for cognitive performance after stroke?

    ✓ Peer-reviewed Cognitive tests and assessment Journal of neurology

    Key finding: Neuropsychological testing is time-consuming and not easy to administer after hospital discharge. +3 more findings

  7. 2009-11-19

    Hypertension and dementia

    ✓ Peer-reviewed Prevention and risk American journal of hypertension

    Key finding: Recent studies have shown that disruption of diurnal blood pressure (BP) variation is closely associated with cognitive impairment via injury of the small cerebral arteries indicating that long-standing hypertension constitutes a risk of brain matter atrophy or white matter lesions (WMLs).

  8. 2009-11-18
  9. 2009-11-18

    Allosteric modulation of PS1/gamma-secretase conformation correlates with amyloid beta(42/40) ratio

    ✓ Peer-reviewed Tau biomarkers PloS one

    Key finding: Presenilin 1(PS1) is the catalytic subunit of gamma-secretase, the enzyme responsible for the Abeta C-terminal cleavage site, which results in the production of Abeta peptides of various lengths. +3 more findings

  10. 2009-11-18
  11. 2009-11-17

    Changing perspectives regarding late-life dementia

    ✓ Peer-reviewed Brain tissue and pathology Nature reviews. Neurology

    Key finding: Development of effective preventive and treatment strategies for late-life dementia relies on a deep understanding of all the processes involved. +3 more findings

  12. 2009-11-17

    CSF phospho-tau is independent of age, cognitive status and gender of neurological patients

    ✓ Peer-reviewed Tau biomarkers Journal of neurology

    Key finding: Unlike total-tau (t-tau), age related changes of this promising biomarker are sparsely studied. +3 more findings

  13. 2009-11-17

    Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease

    ✓ Peer-reviewed Treatments Neurobiology of aging

    Key finding: The plasma Aβ40/Aβ42 ratio increased in the control group, but showed no significant change in the pioglitazone group. +1 more finding

  14. 2009-11-16

    Does neuroinflammation fan the flame in neurodegenerative diseases?

    ✓ Peer-reviewed Inflammation and the immune system Molecular Neurodegeneration

    Key finding: Neurodegenerative CNS disorders, including multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), tauopathies, and age-related macular degeneration (ARMD), are associated with chronic neuroinflammation and elevated levels of several cytokines.

  15. 2009-11-13

    Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease

    ✓ Peer-reviewed Brain scans and imaging Brain : a journal of neurology

    Key finding: Recent imaging evidence in Alzheimer's disease suggests that neural involvement in early-stage disease is more complex than is encapsulated in the commonly held position of predominant mesial temporal lobe degeneration-there is also early posterior cingulate cortex and diencephalic damage. +4 more findings

  16. 2009-11-13

    Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment Neuroscience letters

    Key finding: Some studies have demonstrated an accumulation of products of free radical damage in the central nervous system and in the peripheral tissues of subjects with AD or mild cognitive impairment. +3 more findings

  17. 2009-11-12

    Epidemiological studies of the effect of stroke on incident dementia: a systematic review

    ✓ Peer-reviewed Vascular contributions Stroke

    Key finding: The effect of stroke on dementia incidence in the population is not explained by common risk factors. +3 more findings

Browse the library by subject, with the full score breakdown →